Cargando…
In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice
Nitrogen-containing bisphosphonates (N-BP), including zoledronic acid (ZOL) and alendronate (ALD), have been proposed as sensitisers in γδ T cell immunotherapy in pre-clinical and clinical studies. Therapeutic efficacy of N-BPs is hampered by their rapid renal excretion and high affinity for bone. L...
Autores principales: | Hodgins, Naomi O., Al-Jamal, Wafa' T., Wang, Julie T-W., Parente-Pereira, Ana C., Liu, Mao, Maher, John, Al-Jamal, Khuloud T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science Publishers
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5073077/ https://www.ncbi.nlm.nih.gov/pubmed/27664328 http://dx.doi.org/10.1016/j.jconrel.2016.09.023 |
Ejemplares similares
-
Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy
por: Hodgins, Naomi O., et al.
Publicado: (2017) -
Organ Biodistribution of Radiolabelled γδ T Cells Following Liposomal Alendronate Administration in Different Mouse Tumour Models
por: Wang, Julie T-W., et al.
Publicado: (2020) -
Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo
por: Hassan, Hatem A.F.M., et al.
Publicado: (2016) -
Cationic Liposome- Multi-Walled Carbon Nanotubes Hybrids for Dual siPLK1 and Doxorubicin Delivery In Vitro
por: Pereira, Sara, et al.
Publicado: (2015) -
Synergy between liposomal zoledronic acid and γδ T-cells in the treatment of epithelial ovarian cancer
por: Pereira, Ana Catarina Parente, et al.
Publicado: (2013)